GALT

Q: What is the price of Galectin Therapeutics (GALT) today?

The price of Galectin Therapeutics (GALT) today is $ 2.67, with return of 102.27% compared to the last year. The price of Galectin Therapeutics (GALT) started the year trading around $ 4.16 and today it is at $ 2.67. Follow the real-time price chart, the historical price of Galectin Therapeutics (GALT) and international markets.

Q: When does Galectin Therapeutics (GALT) pay dividends?

Galectin Therapeutics (GALT) did not distribute dividends in the last year.

Q: Is Galectin Therapeutics (GALT) worth it?

Currently, Galectin Therapeutics (GALT) is priced at $ 2.67, with a P/E of -5.63%, representing a deviation of -269% from its historical average P/E. In the last year, the stock showed a variation of 102.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 102.27%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Galectin Therapeutics (GALT) stock?

Investing in stocks of Galectin Therapeutics (GALT) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Galectin Therapeutics (GALT) yield today?

The yield of Galectin Therapeutics (GALT) was -11.88% in the last month, 102.27% in the last year and -4.64% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Galectin Therapeutics (GALT) today, the total investment would be $ 267.00, based on the current price of $ 2.67.If past performance were to repeat, the return on your investment would be:In 1 year: $ 540.06In 5 years: $ 254.61In 10 years: $ 448.35It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Galectin Therapeutics Inc.

Price

$ 2.67

return (12m)

102.27%

p/e

-5.63

p/bv

-1.38

DIVIDEND YIELD

0.00%

GALT price

GALT

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment GALT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.88%

3 months

-34.07%

1 year

102.27%

2 years

-11.00%

5 years

-4.64%

10 years

67.92%

Fundamentals GALT

review the fundamentals of Galectin Therapeutics shares

P/E

-5.63

Sector: -5.82 Industry: -5.82

P/S (PSR)

Sector: -4.74 Industry: -4.74

P/BV

-1.38

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-157.86%

Sector: -72.38% Industry: -72.38%

ROE

24.43%

Sector: -84.15% Industry: -84.15%

ROIC

-20.96%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

0.00%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

0.00%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

0.00%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

-7.40

Sector: -5.52 Industry: -5.52

EV/EBIT

-7.38

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

8.89

Sector: 1.13 Industry: 1.13

BVPS

-1.94

Sector: 1.63 Industry: 1.63

EPS

-0.47

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

-6.46

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

7.46

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-3.77%

Sector: - Industry: -

Fundamentals GALT

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

GALT Historical Dividends

current DY: %

5-year average DY: %

no dividend paid in the period.

ABOUT Galectin Therapeutics

Galectin Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

25 years

Founded: 2001

2002

Time since IPO - 24 years

6

Employees

The Company Galectin Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 173.55 Millions, having an equity of $ -126.19 Millions.

With a total of 6 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -30.83 Millions.

As for its main indicators, the Company has a P/E ratio of -5.63, a P/BV ratio of -1.38 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker GALT.

Market cap

$ 173.55 Millions

Net worth

$ -126.19 Millions

US$ -126,190,000.00

Assets

$ 19.53 Millions

US$ 19,530,000.00

Total Shares Outstanding

65.00 Millions

65,000,000

Average Daily Trading Volume

$ 303.35 Thousand

US$ 303,354.00

Sector

Health Care

Industry

Biotechnology

GALT

GALT revenue and profits

Financial Results GALT

DRAG THE FRAME TO SEE MORE DATA

GALT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Galectin Therapeutics (GALT) today?

The price of Galectin Therapeutics (GALT) today is $ 2.67, with return of 102.27% compared to the last year. The price of Galectin Therapeutics (GALT) started the year trading around $ 4.16 and today it is at $ 2.67. Follow the real-time price chart, the historical price of Galectin Therapeutics (GALT) and international markets.

When does Galectin Therapeutics (GALT) pay dividends?

Galectin Therapeutics (GALT) did not distribute dividends in the last year.

Is Galectin Therapeutics (GALT) worth it?

Currently, Galectin Therapeutics (GALT) is priced at $ 2.67, with a P/E of -5.63%, representing a deviation of -269% from its historical average P/E. In the last year, the stock showed a variation of 102.27 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 102.27%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Galectin Therapeutics (GALT) stock?

Investing in stocks of Galectin Therapeutics (GALT) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Galectin Therapeutics (GALT) yield today?

The yield of Galectin Therapeutics (GALT) was -11.88% in the last month, 102.27% in the last year and -4.64% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Galectin Therapeutics (GALT) today, the total investment would be $ 267.00, based on the current price of $ 2.67.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 540.06
In 5 years: $ 254.61
In 10 years: $ 448.35

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GALT

Galectin Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GALT

review the fundamentals of Galectin Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: %

5-year average DY: %

ABOUT Galectin Therapeutics

Galectin Therapeutics Inc.

United States

25 years

2002

6

PROFIT X PRICE GALT

Financial Results GALT

GALT cash flow

Asset, Revenue and Profit Growth - GALT

GALT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions